Search for Teva Pharmaceutical Industries Ltd and
    1. July 29, 2015

      Wanted: recreational drug users with a nose for business

      Wanted: drug abuser who enjoys snorting opioids. Will pay $250 a day. Thousands of recreational drug users are being...

    2. July 28, 2015

      Pfizer chief executive has ‘sufficient courage’ to pursue deals

      Pfizer is scouting for acquisition targets and has “sufficient courage” to spend its cash on another company, its chief...

    1. July 27, 2015

      Pharma M&A: portfolio theory

      Friendly M&A is cheaper and simpler than the hostile variety. Luckily for Teva Pharmaceutical it had a choice. On...

    2. July 27, 2015

      Weak sales outlook hits machinery makers

      Machinery stocks were under pressure on Monday after analysts at Goldman Sachs issued a downgrade, saying they have not...

    3. July 27, 2015

      Mylan share price plunges after Teva abandons bid

      Shares in drugmaker Mylan plunged almost 14 per cent on Monday after Israeli group Teva Pharmaceutical abandoned its...

    4. July 27, 2015

      Allergan still on the move with $41bn Teva deal

      Having pulled off the biggest takeover of last year, Allergan, the owner of blockbuster wrinkle treatment Botox, is at...

    5. July 26, 2015

      Teva closes in on Allergan’s generics unit

      Teva Pharmaceutical, the Israeli drugmaker, is nearing a deal to acquire Allergan’s generics drug unit for between...

    6. July 6, 2015

      Teva set to lift Mylan bid to up to $43bn

      Teva, the Israeli drugmaker, is preparing to increase its offer for US rival Mylan to as much as $43bn as soon as this...

    7. June 22, 2015

      US appetite for hostile takeovers hits post-crisis high

      Nearly $108bn in potential deals were rejected over the weekend amid a boom in US hostile takeover attempts not seen...

    8. June 1, 2015

      Mylan tells Teva to ‘stop playing games’

      Mylan, a leading generics drugmaker, on Monday demanded that its rival Teva “stop playing games” and either turn its...

    9. May 28, 2015

      Teva pays $1.2bn in US antitrust drugs case

      Teva Pharmaceuticals has agreed to pay $1.2bn over allegations it broke competition law in a record settlement that...

    10. May 12, 2015

      Pharma M&A: Taking stock

      One sign of a top in the merger market is that more deals are done with shares, rather than all in cash. Acquirers —...

    11. May 12, 2015

      Teva bids for Mylan amid pressure on copycat drugmakers

      If timing is everything, then Teva, the world’s biggest maker of generic drugs, has chosen a tricky moment to try to...

    12. April 29, 2015

      Perrigo rebuffs sweetened $35.6bn offer from Mylan

      Mylan, one of the world’s biggest generic drug groups, increased its offer to buy Perrigo to $35.6bn, its latest effort...

    13. April 27, 2015

      Mylan rounds on Teva as it rejects $40bn bid

      Mylan has rejected a $40bn takeover bid from Israel’s Teva, a generic drugs rival double its size, and confirmed its...

    14. April 26, 2015

      No end in sight to wave of pharma dealmaking

      Since the start of last year, pharmaceuticals companies have agreed $462bn of mergers and acquisitions — greater than...

    15. April 24, 2015

      Three-way merger battle in drugs industry hots up

      Perrigo rejected a formal takeover offer from its bigger generic drugs rival Mylan, escalating a three-way takeover...

    16. April 22, 2015

      Mylan readies its poison pill defences

      Israel’s Teva faces an uphill battle in its $40bn takeover pursuit of rival generics drugmaker Mylan, thanks to recent...

    17. April 21, 2015

      Teva seeks cushion against loss of patent protection

      Teva Pharmaceuticals’ $40bn takeover offer for Mylan thrusts into the spotlight a company that has long been a pillar...

    18. April 21, 2015

      Teva/Mylan: brand management

      Could a branded drug be the impetus for dealmaking among generics manufacturers? On Tuesday, Israeli Teva...

    19. April 21, 2015

      Harley-Davidson brakes on lower shipment forecasts

      Harley-Davidson shares were on of the biggest decliners on the S&P 500, after the company lowered its 2015 motorcycle...

    20. April 21, 2015

      Israel’s Teva offers $40.1bn for US drugmaker Mylan

      Teva, the largest generic drugmaker in the world, set the stage for the biggest pharma deal of 2015 by launching an...

    21. April 17, 2015

      Mylan dismisses takeover interest from Teva Pharmaceuticals

      Israel’s Teva Pharmaceuticals is considering a bid to acquire rival generic drugmaker Mylan even as the $33bn US...

    22. March 30, 2015

      UnitedHealth pays $13bn for drug-benefits manager amid deal flurry

      The largest US health insurer is to spend almost $13bn to buy a company that manages prescription medicines for 35m...

    23. October 3, 2014

      Mylan surges after guidance lift

      Mylan climbed after the Pennsylvania-based pharmaceutical company lifted its third-quarter guidance on recent product...

    24. August 3, 2014

      Private equity eyes drug brands purchase

      Private equity groups are exploring a $10bn plan to buy hundreds of older drug brands from GlaxoSmithKline and Sanofi...

    25. July 14, 2014

      Teva faces fresh shareholder showdown over management structure

      Teva is facing a fresh confrontation with shareholders after an activist investor accused the drugmaker of reneging on...

    26. July 9, 2014

      European regulators fine Servier of France

      European regulators have fined Servier of France and several other drugmakers €428m for blocking the introduction of...

    27. June 15, 2014

      Women in Business – Shira Kaplan, MBA student

      Shira Kaplan is an MBA student currently studying on the part-time programme at the University of St Gallen in...

    28. May 23, 2014

      Teva: optimism, unfortunately

      Value investing in one tweet: when the worst-case scenario is for sale at fair value, buy it. The primary US patent on...

    29. May 1, 2014

      Pharma deals reach new level of intensity

      Pfizer wants to buy AstraZeneca, which has been linked with a move for Shire, which is reportedly wanted by Allergan,...

    30. January 23, 2014

      Teva seeks experience in board shake-up

      Teva has bowed to pressure from activist shareholders, saying it plans to slim down its board and recruit more...

    31. January 10, 2014

      Letter from Lex: a new beginning

      Happy Friday, readers. The first week with a new Head of Lex in the London office – an American, no less – is almost...

    32. January 9, 2014

      Teva names Vigodman as chief executive

      Teva of Israel has sought to draw a line under months of turmoil at the world’s largest generic drugmaker by naming...

    33. January 6, 2014

      Teva: in need of a shot

      The board of Teva Pharmaceuticals is a brains trust of scientific and medical knowledge. Shame that so few of its 16...

    34. January 6, 2014

      Teva activist investor backs nomination of Erez Vigodman as chief

      A leading activist shareholder in Teva has lent his support to the proposed nomination of one of the directors of the...

    35. December 29, 2013

      Accusations of insularity and interference haunt the Teva board

      Even by the standards of the regular leaks of sensitive corporate material from Teva, images on Israeli television last...

    36. December 29, 2013

      Teva shareholders press for boardroom shake up

      Leading shareholders in Teva, the world’s largest generic medicines company, are stepping up pressure for a boardroom...

    37. December 6, 2013

      How time and focus give non-executives extra oomph

      Hands-off directors and troubled banks seem to go hand in hand – or at least they have this decade. Sir David Walker’s...

    38. December 4, 2013

      Teva interim chief in favour of board diversity

      The interim chief executive of Teva has said he would welcome a more diversified board of directors as the governance...

    Search for Teva Pharmaceutical Industries Ltd and